GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
688062 Mabwell
- 15.69
- +0.09+0.58%
Market Closed Jan 24 15:00 CST
6.27BMarket Cap-5.84P/E (TTM)
15.85High15.44Low34.22KlotVolume15.60Open15.60Pre Close53.53MTurnover1.68%Turnover RatioLossP/E (Static)399.60MShares37.0052wk High3.27P/B3.20BFloat Cap15.3652wk Low18.72Limit Up204.17MShs Float37.00Historical High12.48Limit Down2.63%Amplitude12.96Historical Low--Dividend TTM15.64Avg Price14.03KlotAsk--Div YieldTTM100Lot Size18.93KlotBid
Mabwell News
Maiwei Biotech: Maiwei Biotech\'s announcement on continuing to use some temporarily idle funds raised for cash management
Maiwei Biotech: Announcement of Resolutions of the 15th Meeting of the 2nd Supervisory Board of Maiwei Biotech
Maiwei Biology: Opinions of Haitong Securities Co., Ltd. on the continued use of some temporarily idle funds raised by Maiwei (Shanghai) Biotechnology Co., Ltd. for cash management
Haitong Securities Co., Ltd.\'s verification opinion on Maiwei (Shanghai) Biotechnology Co., Ltd. continuing to use some temporarily idle funds raised for cash management
Maiwei Biotech\'s announcement on continuing to use some temporarily idle funds raised for cash management
Announcement of Resolutions of the 15th Meeting of the 2nd Supervisory Board of Maiwei Biotech
Maiwei Biotech: Maiwei Biotech voluntarily disclosed the announcement that 9MW2821 combined with treprimab was included in the public list of breakthrough treatment varieties for first-line treatment of urothelial cancer
Maiwei Biotech voluntarily disclosed an announcement on the inclusion of 9MW2821 and treprilizumab in the first-line treatment of urothelial cancer in the public list of breakthrough treatment varieties
Maiwei Biotech: Announcement on the submission of an application for the issuance and listing of H shares to the Hong Kong Stock Exchange and publication of application materials
Maiwei Biotech: Maiwei Biotech\'s announcement on opening a special fund raising account and signing a tripartite supervisory agreement for fund raising special account storage
Announcement of Maiwei Biotech\'s submission of an application for the issuance and listing of H shares to the Hong Kong Stock Exchange and publication of application materials
Maiwei Biotech Investor Relations Activity Record List (December 1, 2024)
Maiwei Biotech: “Management System for Related (Connected) Transactions with Maiwei (Shanghai) Biotechnology Co., Ltd.” (Draft)
Maiwei Biotech: Announcement of Resolutions of the 15th Meeting of the 2nd Board of Directors of Maiwei Biotech
Maiwei Biotech: Miwei Biotech\'s indicative announcement on matters relating to the company\'s planning to issue H shares and go public on the Hong Kong Stock Exchange Limited
Maiwei Biotech: Resolutions of the 2nd Meeting of the 2nd Special Meeting of Independent Directors of Maiwei Biotech\'s Board of Directors
Maiwei Biotech: Review Opinions of the 2nd Meeting of the Nomination Committee of the 2nd Maiwei Biotech Board of Directors
Maiwei Biology: “Maiwei (Shanghai) Biotechnology Co., Ltd. Director Nomination Policy” (draft)
Maiwei Biotech: “Maiwei (Shanghai) Biotechnology Co., Ltd. Shareholder Communications Policy” (draft)
Maiwei Biotech: Maiwei Biotech\'s announcement on expected daily related transactions in 2025